Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BICYCLE THERAPEUTICS plc | Director | Ordinary Shares | 16.8K | $293K | $17.50 | Jan 2, 2024 | Direct |
Longeveron Inc. | Director | Class A Common Stock | 16K | $23.3K | $1.46 | May 10, 2024 | Direct |
Seres Therapeutics, Inc. | Director | Stock Option (right to buy) | 60K | Apr 4, 2024 | Direct | ||
Omega Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 50K | Jun 20, 2024 | Direct | ||
BICYCLE THERAPEUTICS plc | Director | Stock Option (right to buy) | 12K | Jan 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OMGA | Omega Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
OMGA | Omega Therapeutics, Inc. | Jun 20, 2024 | 0 | $0 | 3 | Jun 21, 2024 | Director |
LGVN | Longeveron Inc. | May 10, 2024 | 1 | $23.3K | 4 | May 14, 2024 | Director |
LGVN | Longeveron Inc. | May 10, 2024 | 0 | $0 | 3 | May 14, 2024 | Director |
MCRB | Seres Therapeutics, Inc. | Apr 4, 2024 | 1 | $0 | 4 | Apr 8, 2024 | Director |
BCYC | BICYCLE THERAPEUTICS plc | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
BCYC | BICYCLE THERAPEUTICS plc | Jan 3, 2023 | 2 | $0 | 4 | Jan 5, 2023 | Director |
MCRB | Seres Therapeutics, Inc. | Jul 5, 2022 | 1 | $200K | 4 | Jul 6, 2022 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
BCYC | BICYCLE THERAPEUTICS plc | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | Director |
MCRB | Seres Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |